Latest FDA approval News
FDA takes steps to enhance state importation programs to help lower prescription drug prices
The U.S. Food and Drug Administration is continuing…
FDA approves Amneal’s self-administered migraine drug Brekiya
The US Food and Drug Administration (FDA) has…
FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public
As part of the Trump Administration’s commitment to…
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
New Test Provides Less Invasive Option, Reduces Reliance…
FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
The U.S. Food and Drug Administration announced its…
FY 2024 GDUFA Science and Research Report
FDA’s generic drug Science and Research Program, created…
FDA Approves First Digital Therapeutic for Preventive Treatment of Episodic Migraine
In a major step forward for digital health,…
FDA approves durvalumab for muscle invasive bladder cancer
The Food and Drug Administration approved durvalumab (Imfinzi,…
HHS, FDA to Phase Out Petroleum-Based Synthetic Dyes in Nation’s Food Supply
The U.S. Department of Health and Human Services…
FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
The U.S. Food and Drug Administration approved Qfitlia…
